STERIS STE Income Statement
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| $5.94B+8.7% | $5.83B+8.0% | $5.7B+7.1% | $5.57B+6.4% | $5.46B+6.2% | ||
| $3.31B+8.3% | $3.26B+6.7% | $3.18B+4.8% | $3.11B+4.7% | $3.06B+4.7% | ||
| $2.63B+9.3% | $2.57B+9.6% | $2.53B+10.1% | $2.46B+8.7% | $2.4B+8.3% | ||
| 44.2%+0.2pp | 44.1%+0.7pp | 44.3%+1.2pp | 44.1%+0.9pp | 44%+0.8pp | ||
| $112.9M+4.9% | $111.7M+3.9% | $109.6M+4.0% | $108.4M+3.6% | $107.6M+3.8% | ||
| $1.41B+5.5% | $1.39B+6.1% | $1.37B+7.1% | $1.35B+5.6% | $1.33B+6.5% | ||
| $4.4M-90.4% | $19.7M-65.3% | $21.5M-60.6% | $22.1M-57.2% | $46M+76.9% | ||
| $1.52B-0.7% | $1.57B+6.5% | $1.55B+7.6% | $1.53B+6.5% | $1.54B+11.1% | ||
| $1.52B-0.7% | $1.57B+6.5% | $1.55B+7.6% | $1.53B+6.5% | $1.54B+11.1% | ||
| $1.1B+27.1% | $1B+15.0% | $973.2M+14.2% | $927.1M+12.5% | $866.6M+3.6% | ||
| 18.6%+2.7pp | 17.2%+1.0pp | 17.1%+1.1pp | 16.6%+0.9pp | 15.9%-0.4pp | ||
| $60.8M-29.6% | $62.9M-40.3% | $67.1M-46.4% | $71.9M-49.5% | $86.4M-40.2% | ||
| -$54.4M+22.7% | -$60.9M+25.1% | -$62.1M+38.9% | -$74.2M+34.1% | -$70.4M+47.2% | ||
| $1.05B+31.6% | $940.1M+19.1% | $911M+21.4% | $852.8M+19.9% | $796.1M+13.3% | ||
| $262.2M+42.0% | $228.5M+33.3% | $220.4M+40.3% | $203.3M+36.8% | $184.7M+23.5% | ||
| $782.4M+27.3% | $707.8M+51.4% | $688.4M+58.3% | $646.5M+61.6% | $614.5M+62.5% | ||
| 13.2%+1.9pp | 12.1%+3.5pp | 12.1%+3.9pp | 11.6%+4.0pp | 11.3%+3.9pp | ||
| —— | —— | —— | —— | —— | ||
| $0.00— | —— | —— | —— | —— | ||
| $7.93+28.1% | $7.16+52.0% | $6.95+58.7% | $6.52+61.8% | $6.19+62.0% | ||
| $7.96+27.6% | $7.20+51.9% | $7.00+59.1% | $6.57+62.2% | $6.24+62.9% | ||
| $0-100% | $12.05M-66.7% | $24.1M0.0% | $36.15M+200% | $48.2M— | ||
| $7.96+28.8% | $7.2+15.4% | $7+17.1% | $6.57+15.9% | $6.18+10.8% | ||
| $7.93+28.9% | $7.17+15.5% | $6.96+17.0% | $6.53+15.8% | $6.15+11.0% | ||
| $0.00— | —— | —— | —— | —— | ||
| $2.46+10.3% | $2.40+10.1% | $2.34+9.9% | $2.28+9.6% | $2.23+9.9% | ||
| $9.9M+19.3% | $10.6M-4.6% | $10.1M-6.4% | $8.8M-19.4% | $8.3M-24.5% | ||
| —— | —— | —— | —— | —— | ||
| $1.59B+18.3% | $1.49B+9.4% | $1.46B+7.9% | $1.41B+3.4% | $1.34B-4.2% | ||
| 26.8%+2.2pp | 25.5%+0.3pp | 25.6%+0.2pp | 25.3%-0.7pp | 24.6%-2.7pp | ||
| $1.1B+27.1% | $1B+15.0% | $973.2M+14.2% | $927.1M+12.5% | $866.6M+3.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is STERIS's revenue?
- STERIS (STE) generated $5.9B in revenue over the trailing twelve months, up 8.7% year over year.
- Is STERIS profitable?
- STERIS reported $782.4M in net income over the trailing twelve months, a 13.2% net margin.
- What are STERIS's profit margins?
- Gross margin is 44.2% and operating margin is 18.6%, with a 13.2% net margin.
- What is STERIS's earnings per share?
- STERIS's diluted EPS over the trailing twelve months is $7.93.
- Where does STERIS's income statement data come from?
- Every line is extracted from STERIS's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
